Visit Oriental Bank
NYSE : OFG
$9.25
$ (0.10) - (1.09)%

Insider Ownership

Insider Ownership

Click on an individual's name to see their transaction history.

Insider Transaction Activity (Last 6 Months)
Aggregates Shares Price ($) Value ($)
Open Market Buys 5,000 7.95 39,740
Open Market Sells 0 -- --
Options Ex. & Sold 0 -- --
Net Shares 5,000 7.95 39,740

High Volume Traders (Last 6 Months)
Name #Buys #Sells # Options Ex. & Sold Total # Trans. Net Shares
Néstor De Jesús 2 0 0 2 5,000

Insider Ownership
Transaction Date Name Action Shares Price ($) Value ($) Type Report Date
11/8/2017 Buy 4,600 7.95 36,570 Direct 11/9/2017
Open market or private purchase of non-derivative or derivative security
11/8/2017 Buy 400 7.93 3,170 Direct 11/9/2017
Open market or private purchase of non-derivative or derivative security
3/28/2017
Maritza Arizmendi
Chief Financial Officer and Executive Vice President
Buy 600 -- -- Direct 3/29/2017
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
3/27/2017
Rafael F. Martínez-Margarida
Independent Director
Buy 800 -- -- Direct 3/29/2017
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
3/8/2017
Juan Carlos Aguayo
Independent Director and Director of Oriental Bank & Trust
Buy 1,200 -- -- Direct 3/9/2017
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
3/7/2017
Pedro Morazzani Ferrer
Independent Director and Director of Oriental Bank & Trust
Buy 1,500 -- -- Direct 3/8/2017
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
3/7/2017
Julian S. Inclán
Chairman of the Board and Chairman of Oriental Bank & Trust
Buy 2,300 -- -- Direct 3/8/2017
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
3/7/2017
Carlos O. Souffront
General Counsel and Secretary
Buy 12,300 -- -- Direct 3/8/2017
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
3/6/2017
Ganesh Kumar
Chief Operating Officer and Senior Executive Vice President
Sell (5,047) 12.73 (64,223) Indirect 3/8/2017
Open market or private sale of non-derivative or derivative security
3/2/2017
Ramón A. Rosado
Senior Vice President and Treasurer
Buy 600 -- -- Direct 3/3/2017
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
3/2/2017
Carlos O. Souffront
General Counsel and Secretary
Sell (5,000) 13.50 (67,500) Direct 3/3/2017
Open market or private sale of non-derivative or derivative security
3/2/2017
Carlos O. Souffront
General Counsel and Secretary
Sell (902) 13.43 (12,114) Direct 3/3/2017
Open market or private sale of non-derivative or derivative security
3/2/2017
Carlos O. Souffront
General Counsel and Secretary
Sell (700) 13.41 (9,387) Direct 3/3/2017
Open market or private sale of non-derivative or derivative security
3/2/2017
Carlos O. Souffront
General Counsel and Secretary
Sell (298) 13.40 (3,993) Direct 3/3/2017
Open market or private sale of non-derivative or derivative security
3/2/2017
Ganesh Kumar
Chief Financial Officer and Executive Vice President
Sell (3,642) 13.39 (48,763) Indirect 3/2/2017
Open market or private sale of non-derivative or derivative security
3/2/2017
José Rafael Fernández
Vice Chairman, Chief Executive Officer, President and Direct
Sell (1,700) 13.50 (22,950) Direct 3/3/2017
Open market or private sale of non-derivative or derivative security
3/1/2017
Julian S. Inclán
Chairman of the Board, Chairman of Compensation Committee, M
Sell (2,300) 13.55 (31,165) Direct 3/3/2017
Open market or private sale of non-derivative or derivative security
3/1/2017
Ganesh Kumar
Chief Financial Officer and Executive Vice President
Sell (5,603) 13.43 (75,220) Indirect 3/2/2017
Open market or private sale of non-derivative or derivative security
3/1/2017
Carlos O. Souffront
General Counsel and Secretary
Sell (3,100) 13.52 (41,912) Direct 3/3/2017
Open market or private sale of non-derivative or derivative security
3/1/2017
Ganesh Kumar
Chief Financial Officer and Executive Vice President
Buy 785 -- -- Direct 3/3/2017
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3